
Opinion|Videos|May 14, 2025
Q&A: Getting Started with Point-of-Care Testing in Community Pharmacy
Author(s)Duane Jones, BS Pharm
A panelist discusses how medication synchronization programs are essential for implementing point-of-care testing by making half of prescription volume nonurgent, allowing pharmacists to delegate work and free up time for clinical services.
Advertisement
Episodes in this series

Q&A – Getting Started with Implementation
Main Discussion Topics:
- Initial steps for implementing point-of-care testing in community pharmacy
- Time management and workflow integration
- Pharmacist acceptance and adoption process
Key Points for Physicians:
- State regulations for pharmacy-based testing vary significantly; consultation with board of pharmacy is essential
- Pharmacies handling up to 900 prescriptions daily successfully integrate testing without additional staffing
- Medication synchronization programs create necessary capacity for clinical services
Notable Insights:
- The greatest initial challenge is often pharmacist comfort with new clinical roles
- Pharmacists typically report high satisfaction with expanded clinical services once these are implemented
- Delegation to pharmacy technicians is essential for successful integration
Clinical Significance:
Implementing point-of-care testing requires initial workflow redesign and staff training but creates sustainable clinical service opportunities that enhance professional satisfaction while improving patient access to care.
Advertisement
Related to this article

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.

In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.

In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.

Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration
2
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
3
Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed
4
Integrated Care and the Keys to Successful GLP-1 Therapy
5


